Capital Group Dividend Growers ETF
Capital Group Dividend Growers ETF · 1 share class
Fund classification
Classified from what the fund holds · as of 2026 Q2
Capital Group Dividend Growers ETF is an actively managed global equity ETF.
- Asset class
- Equity
- Region
- Global
- Management
- Actively managed
- Fund type
- ETF
- Features
- Non-diversified
Fund profile
As filed in the prospectus · 2025 Q3
The funds investment objective is to provide long-term total returns.
The fund invests primarily in common stocks of dividend-paying companies worldwide, selected for current yield and forecast dividend growth based on financial health. It normally holds at least 80% of assets in equity securities and at least 80% in dividend-paying companies, with significant exposure outside the United States including emerging markets. The fund is nondiversified, meaning it may invest a greater portion of its assets in fewer issuers than would otherwise be the case. Because security selection depends on the adviser's assessment of dividend yield, history, and growth prospects, portfolio performance will diverge from any benchmark.
| Share class | Expense ratio |
|---|---|
| CGDG | 0.47% |
Portfolio turnover 25.00% · as of 2025 Q3
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 99.72% |
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| International | 49.7% |
| Financials | 9.4% |
| Information Technology | 7.7% |
| Health Care | 6.1% |
| 9 smaller | 27.1% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Latest quarter
What changed since the fund's previous filing
New: Royalty Pharma PLC, Roche Holding AG, MRK, BNP Paribas SA, Hana Financial Group Inc, Amcor PLC, Cenovus Energy Inc, Samsung Electronics Co Ltd
Exited: IP, FDX, Amcor PLC, London Stock Exchange Group PLC, America Movil SAB de CV, BMY, Roche Holding AG, Deutsche Bank AG
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
May 2026 has been filed since the trailing figures were struck, so it is not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| AVGO | Broadcom IncAVGO | 4.63% | $446.77 | $234.19M | 524.2K |
| TSM | Taiwan Semiconductor Manufacturing Co LtdTSM | 4.23% | $418.45 | $213.82M | 511.0K |
| PM | Philip Morris International IncPM | 3.71% | $177.38 | $187.85M | 1.1M |
| — | AstraZeneca PLC | 2.62% | $185.87 | $132.79M | 714.4K |
| — | TotalEnergies SE | 2.08% | $87.69 | $105.11M | 1.2M |
| — | British American Tobacco PLC | 2.05% | $61.83 | $103.65M | 1.7M |
| WELL | Welltower IncWELL | 1.99% | $205.33 | $100.75M | 490.7K |
| — | Iberdrola SA | 1.63% | $22.74 | $82.46M | 3.6M |
| ABBV | AbbVie IncABBV | 1.58% | $217.72 | $79.97M | 367.3K |
| — | Marubeni Corp | 1.50% | $32.62 | $76.00M | 2.3M |
Reported price is the fund's own reported value divided by its own reported shares at 2026-05-31 — not a live quote, and not what the fund paid.
Top 10 positions are 26.02% of net assets, top 25 44.65%, across 102 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free